Molecular Architecture
Formulations are constructed at the level of molecular interaction, where structure defines function.
Omnia Health Sciences is a translational science platform engineered to convert advanced molecular research into precision-driven human performance formulations. From laboratory discovery through clinical validation, we bridge the critical gap between scientific knowledge and real-world application consolidating the world’s most sophisticated research into a singular, uncompromising standard of efficacy, trust, and performance.
We do not only manufacture products. We architect biological outcomes.
Every formulation is built through molecular reasoning, grounded in evidence, and defined within structured scientific systems.
Outcomes are not assumed — they are engineered, measured, and consistently reproduced.
Formulations are constructed at the level of molecular interaction, where structure defines function.
Scientific understanding is carried through — from research to formulation — with integrity preserved at every step.
Each formulation is supported by a documented framework of composition, testing, and performance.
Formulations align with globally recognized systems governing quality, consistency, and control.
Omnia is shaped by the lifetime scientific contributions of Prof. Shaker A. Mousa and Prof. Steve Harakeh — bringing together patents, peer-reviewed research, translational science, and clinical understanding into one scientific foundation.

PhD · MBA / Fellow NAI · FACC · FACB · FAHA
Ranked among the Top 1% of globally impactful scientists by the Stanford ranking, Prof. Shaker A. Mousa stands at the center of Omnia’s scientific foundation.
A tenured Professor of Pharmacology at Albany College of Pharmacy and Founder of the Pharmaceutical Research Institute in Albany, New York, his lifetime of scientific invention spans pharmacology, vascular biology, drug delivery, nanotechnology, pharmacokinetics, pharmacodynamics, and translational medicine.
His work includes 1,000+ peer-reviewed publications, 400+ U.S. and international patents, 33,000+ citations, an h-index of 90, and an i10-index of 500 — with contributions to FDA-approved products and clinical candidates.
He held senior research roles for over two decades at DuPont Pharmaceuticals, DuPont Merck, and DuPont Imaging, alongside academic appointments at Temple University, SUNY Buffalo/Albany, and Rensselaer Polytechnic Institute.
Prof. Mousa is a Fellow of the National Academy of Inventors, Fellow of the American College of Cardiology, Fellow of the National Academy of Clinical Biochemistry, and Fellow of the American Heart Association. He was awarded the 2017 KFAS Laureate for Applied Sciences in Medicine and the 2020 Sheikh Zayed International Award in Traditional, Complementary and Alternative Medicine.
Molecular reasoning · Bioavailability · Nutrient delivery · Cellular health · Vascular biology · Translational science · Evidence-led formulation

PhD, Microbiology — University of Surrey / Stanford SoM · Linus Pauling Institute
Prof. Steve Harakeh is a globally established scientist in microbiology, immunology, and translational science, with a career spanning leading research institutions across the United States, Europe, and the Middle East.
His scientific foundation includes advanced research at Stanford University School of Medicine, where he spent several years as a Postdoctoral Research Fellow and Research Associate in the Department of Microbiology and Immunology. He subsequently joined the Linus Pauling Institute for Science and Medicine, where he worked and published alongside Professor Linus Pauling, the only scientist in history to hold two unshared Nobel Prizes, contributing to one of the most influential legacies in modern scientific thought.
He was awarded his PhD in Microbiology from the University of Surrey (UK), and held research leadership roles at the Dr. Rath Research Institute (California). His research has contributed to the scientific understanding of microbial ecosystems, immune response, and nutritional-biological interactions, forming a critical bridge between biological science and real-world health application.
He is the Vice Chairman of the KFMRC Quality Control and Biosafety Committee, a member of the infectious disease research group, and has been appointed to the YAJ Research Chair for Prophetic Medicine, where he is actively engaged in ongoing research programs advancing integrated approaches to human health.
Prof. Harakeh is the recipient of multiple international awards and research grants, and has published hundreds of peer-reviewed scientific papers, in addition to contributing chapters to numerous international scientific books.
Microbiology · Immunology · Nutritional Science · Host–Pathogen Interaction · Translational Science · Cellular Response · Evidence-Led Health Systems
Every formulation is developed within a defined scientific framework, structured across four layers that govern how it is reasoned, validated, standardised, and recorded.
Four layers. One controlled system.
Defines how each component behaves at the level of molecular interaction, bioavailability, and biological pathways.
Aligns formulation logic with established scientific literature and practitioner insight to ensure biological relevance.
Ensures identity, quality, and consistency through globally recognised scientific references.
Records sourcing, composition, validation, and outcomes within a structured, auditable system of record.
Omnia operates through a defined progression, transforming scientific insight into a structured, reproducible formulation ready for real-world use.
Scientific opportunity is extracted from founder-led patents and biological research identifying non-generic pathways worth building on.
Selected compounds are structured into a precise composition, balancing dose, compatibility, delivery form, and intended biological function.
Each formulation is reviewed against scientific literature, safety rationale, ingredient standards, and manufacturing feasibility.
The final formulation is documented, standardised, and prepared for production under defined quality and compliance frameworks.
Omnia's advantage begins with ownership.
Its scientific foundation includes 400+ U.S. and internationally registered patents across drug delivery, cellular health, molecular systems, and applied therapeutic innovation.
These patents form the protected scientific base from which Omnia translates proven invention into proprietary food supplement formulations.
Behind every release sits owned science, patented knowledge, formulation discipline, and a controlled path from molecular reasoning to finished product.
Our Brand is the first consumer expression of Omnia's patented scientific foundation — products built to carry the institution's science into daily human performance.
Omnia is built on a documented scientific record — a body of peer-reviewed research, citations, and published work developed by its founding scientists across decades of scientific inquiry in pharmacology, microbiology, human health, vascular biology, and translational science, forming the verified foundation behind every formulation.
Verified · Indexed · Open.
Omnia partners with selected distributors, operators, manufacturers, institutions, and commercial groups capable of carrying science-led formulations into global markets with discipline, compliance, and scale.
Partnership is built on alignment and volume— with partners who can protect the science, respect the process, and grow Omnia's formulations responsibly across markets.